-
Hematoxylin and Eosin Staining Kit: Technical Lab Guidance
2026-07-08
The Hematoxylin and Eosin Staining Kit (SKU: K1142) delivers pre-formulated, ready-to-use solutions for reliable tissue morphology visualization in research applications, streamlining histopathological and cytological staining of paraffin-embedded, frozen, and cytological samples. It is not suitable for diagnostic or clinical use, and its design specifically addresses workflow consistency and staining reproducibility for scientific research.
-
Optimizing mRNA Delivery: Applied Workflows with SM-102 Lipi
2026-07-07
SM-102, a synthetic endosomal escape lipid, is transforming how researchers approach mRNA vaccine development and therapeutic mRNA delivery. This article unpacks the stepwise optimization, critical protocol details, and troubleshooting insights that make SM-102 from APExBIO the cornerstone for reliable, scalable, and tissue-targeted mRNA applications.
-
Acridine Orange hydrochloride: Technical Use & QC Parameters
2026-07-07
Acridine Orange hydrochloride enables precise, dual-fluorescence nucleic acid staining for distinguishing DNA and RNA in cytochemical workflows. It is ideal for cell cycle analysis, apoptosis detection, and flow cytofluorometric applications, but is not suitable for protocols requiring long-term solution stability or unrelated to nucleic acid detection.
-
EdU Imaging Kits (Cy5): Precision DNA Synthesis Measurement
2026-07-06
Discover how EdU Imaging Kits (Cy5) revolutionize cell proliferation analysis by offering precise, artifact-free measurement of S-phase DNA synthesis. This article dives deep into the scientific principles, unique workflow advantages, and practical assay implications for advanced biomedical research.
-
PGE2-Induced Schwann Cell Dedifferentiation Drives PDAC PNI
2026-07-06
This study uncovers how prostaglandin E2 (PGE2) produced by pancreatic ductal adenocarcinoma (PDAC) cells induces Schwann cell dedifferentiation, thereby promoting perineural invasion (PNI)—a central mechanism underlying PDAC’s aggressive behavior. Integrating spatial transcriptomics and functional assays, the authors identify the PTGES-Schwann cell axis as a novel therapeutic target, providing a mechanistic foundation for biomarker development and intervention strategies.
-
Hoechst 33342 Nuclear Stain: Optimizing Live and Fixed Cell
2026-07-05
Hoechst 33342 Solution (1 mg/mL) from APExBIO unlocks advanced nuclear staining for both live and fixed cell workflows, offering superior cell permeability and minimal cytotoxicity. Discover evidence-driven protocol enhancements, troubleshooting tips, and practical insights for mitochondrial quality assays in fibroblast aging research.
-
Dimetridazole: Advanced Workflows for Antimicrobial Synergy
2026-07-04
Dimetridazole (1,2-Dimethyl-5-nitroimidazole) enables next-generation research on multidrug-resistant bacteria through unique antimicrobial and quorum sensing inhibition properties. This guide details applied workflows, troubleshooting, and the latest synergy protocols, bridging bench precision with translational insight.
-
Hematoxylin and Eosin Staining Kit: Practical Research Guide
2026-07-03
The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use solutions for consistent tissue morphology visualization in histopathological and cytological research. It is intended for scientific research use only and is not suitable for diagnostic or clinical applications.
-
SP2509: Lysine-Specific Demethylase 1 Antagonist in AML Rese
2026-07-03
SP2509 stands out as a highly selective Lysine-specific demethylase 1 antagonist for advanced cancer epigenetics research. Its unique disruption of LSD1–CoREST complexes promotes apoptosis and differentiation in AML models, offering robust, reproducible results with optimized experimental workflows.
-
Br-DAPI: Elevating DAPI Fluorescent Dye Workflows in DNA Sta
2026-07-02
Br-DAPI offers unprecedented sensitivity and selectivity for DNA quantification in both live and fixed cell assays. This advanced DAPI fluorescent dye enables robust workflow enhancements, especially for experiments requiring precise nuclear visualization and low-background imaging.
-
DAPI (Hydrochloride): Practical Guide for Chromosome Stainin
2026-07-02
DAPI (hydrochloride) is a DNA-specific fluorescent probe optimized for chromosome staining, DNA visualization, and cell cycle analysis in both fixed and live cells. It addresses the need for precise, reproducible nuclear staining in cytometry and histochemistry workflows. However, limitations in live cell permeability and storage stability should be considered before use.
-
EdU Imaging Kits (HF594): Precision Cell Proliferation in Re
2026-07-01
Discover how EdU Imaging Kits (HF594) empower advanced cell proliferation analysis and DNA synthesis measurement, with a focus on overcoming drug resistance in cancer research. This article delivers a mechanistic and translational perspective not found elsewhere.
-
Partial β-Secretase Inhibition Lowers Amyloid β Without Syna
2026-07-01
Satir et al. demonstrate that moderate inhibition of β-secretase (BACE) reduces amyloid β (Aβ) production by up to 50% without impairing synaptic transmission in cultured neurons. This finding refines therapeutic strategies for Alzheimer’s disease by supporting partial enzyme inhibition as a safer approach.
-
Dimetridazole in Antimicrobial Assays: Protocols and Innovat
2026-06-30
Dimetridazole (1,2-Dimethyl-5-nitroimidazole) is redefining antimicrobial assay design by enabling reliable synergy testing and membrane-targeting workflows in multidrug-resistant models. Explore stepwise protocols, troubleshooting insights, and the latest evidence on its role as a quorum sensing inhibitor and biofilm formation suppressor.
-
Exogenous FLCN mRNA Restores Function in BHD Syndrome Mutant
2026-06-30
This study identifies two rare FLCN mutations in Chinese Birt-Hogg-Dubé (BHD) syndrome families and demonstrates that exogenous FLCN mRNA delivery can restore protein expression and normalize mTORC1 signaling in vitro. These findings expand the pathogenic FLCN mutation spectrum and establish preliminary proof-of-concept for mRNA-based therapeutic strategies in BHD.